These medications work primarily by enhancing glucose-dependent insulin secretion, suppressing glucagon release when glucose levels are elevated, slowing gastric emptying, and reducing appetite through central nervous system pathways
This has implications for clinical applications of the possible treatment to reduce carbohydrate or calorie intake, especially for the overweight and the obese
Further, compared to the Saxenda, the Wegovy offers more than 50% greater weight loss on average, with the typical patient losing 15% of their body weight (34 pounds)
Nat Protoc 1(2):581585 Couto N, Wood J, Barber J (2016) The role of glutathione reductase and related enzymes on cellular redox homoeostasis network
Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia